Format

Send to

Choose Destination
See comment in PubMed Commons below
Hinyokika Kiyo. 2012 Nov;58(11):635-7.

[Side effects of sorafenib and countermeasures].

[Article in Japanese]

Author information

1
The Department of Urology, Osaka Medial Center for Cancer and Cardiovascular Diseases.

Abstract

Administration of more than 400 mg/day of sorafenib for 1 month prolonged progression-free survival (PFS) in Japanese patients with advanced renal cell carcinoma (RCC). This indicated that it is very important to prevent and manage side effects of sorafenib avoiding drug withdrawal or dose reduction. I mention the side effects of sorafenib and countermeasures in this review.

PMID:
23254792
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Kyoto University Resarch Information Repository - Kiyo
    Loading ...
    Support Center